Netflix announced the launch of "MED," its first original medical drama produced in Brazil, during the Rio2C conference in Rio de Janeiro [1].

This move signals a strategic expansion of the streaming platform's content portfolio in South America. By venturing into the medical drama genre, Netflix is diversifying its Brazilian slate to capture a wider range of regional storytelling and audience interests [3].

The new series stars Brazilian actress Clara Moneke [1]. The announcement took place May 27, 2026, at the Rio2C film and TV conference, an event focused on the audiovisual industry in Brazil [1, 2].

"MED" is not the only project the company is introducing. Netflix unveiled five new Brazilian titles at the event [5]. This broader slate includes the exploration of various new genres, including legal dramas, as the company seeks to strengthen its local production footprint [1].

The push for more Brazilian originals reflects a broader industry trend of investing in non-English language content to drive global growth. By focusing on high-production-value dramas in key markets, the company aims to create "local-for-global" hits that resonate both within Brazil and with international viewers [3].

Industry analysts said that the medical drama is a staple of global television, yet it has been underrepresented in Netflix's Brazilian original catalog until now [4]. The inclusion of Moneke, a recognized talent in the region, is intended to draw a significant domestic audience to the series [1].

“Netflix is launching "MED," its first Brazilian medical drama”

The launch of 'MED' represents a pivot toward genre-specific storytelling in the Brazilian market. By moving beyond general dramas and into specialized formats like medical and legal procedurals, Netflix is attempting to mirror the success of US-based prestige dramas while leveraging local talent and cultural contexts to scale its international viewership.